Kota Fujii
About
Kota Fujii is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology.
According to data from OpenAlex, Kota Fujii has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 8 papers in Oncology. Recurrent topics in Kota Fujii's work include Lung Cancer Diagnosis and Treatment (8 papers), Esophageal Cancer Research and Treatment (7 papers) and Gastric Cancer Management and Outcomes (4 papers). Kota Fujii is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Esophageal Cancer Research and Treatment (7 papers) and Gastric Cancer Management and Outcomes (4 papers). Kota Fujii collaborates with scholars based in Japan and India. Kota Fujii's co-authors include Tomoaki Nakajima, Noriyuki Takeda, Kazunori Ida, Junichi Okuda, Takahiro Kato, Takao Kojima, Masahide Hamaguchi, Tatsushi Omatsu, Takayuki Nakagawa and Makoto Shimazaki and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Internal Medicine and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Kota Fujii
27 papers receiving 1.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kota Fujii Japan | 11 | 1.4k | 766 | 506 | 358 | 274 | 32 | 1.8k | ||
| Min‐Sun Kwak South Korea | 24 | 1.1k 0.8× | 416 0.5× | 461 0.9× | 213 0.6× | 235 0.9× | 65 | 1.5k | ||
| Amitabh Suman United States | 17 | 1.1k 0.8× | 520 0.7× | 633 1.3× | 197 0.6× | 508 1.9× | 27 | 1.7k | ||
| Amer Khiyami United States | 20 | 955 0.7× | 700 0.9× | 402 0.8× | 266 0.7× | 469 1.7× | 41 | 1.7k | ||
| Paolo De Paolis Italy | 12 | 1.1k 0.8× | 420 0.5× | 523 1.0× | 182 0.5× | 455 1.7× | 53 | 1.6k | ||
| Myung‐Whun Sung South Korea | 18 | 1.0k 0.7× | 600 0.8× | 407 0.8× | 229 0.6× | 489 1.8× | 40 | 1.9k | ||
| Franco Sasso Italy | 11 | 1.4k 1.0× | 676 0.9× | 608 1.2× | 729 2.0× | 195 0.7× | 20 | 2.1k | ||
| Elsbeth Henderson United Kingdom | 9 | 1.9k 1.3× | 769 1.0× | 1.0k 2.0× | 353 1.0× | 265 1.0× | 12 | 2.1k | ||
| Enrico Mozzi Italy | 20 | 1.2k 0.8× | 592 0.8× | 384 0.8× | 154 0.4× | 524 1.9× | 42 | 1.7k | ||
| Rosa Lombardi Italy | 24 | 1.1k 0.8× | 419 0.5× | 546 1.1× | 199 0.6× | 207 0.8× | 73 | 1.5k | ||
| Paul C.L. Choi Hong Kong | 14 | 1.1k 0.8× | 323 0.4× | 652 1.3× | 176 0.5× | 209 0.8× | 33 | 1.6k |
Countries citing papers authored by Kota Fujii
Since
Specialization
Citations
This map shows the geographic impact of Kota Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kota Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kota Fujii more than expected).
Fields of papers citing papers by Kota Fujii
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kota Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kota Fujii. The network helps show where Kota Fujii may publish in the future.
Co-authorship network of co-authors of Kota Fujii
This figure shows the co-authorship network connecting the top 25 collaborators of Kota Fujii. A scholar is included among the top collaborators of Kota Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kota Fujii. Kota Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fujii, Kota, et al.. (2025). Arm-Behind-the-Back Position for Breast Cancer Radiotherapy in Patients with Lupus Erythematosus and Shoulder Arthropathy: A Case Report. American Journal of Case Reports. 26. e946674–e946674.
2.
Doi, Hiroshi, Yukinori Matsuo, Masakazu Ogura, et al.. (2024). Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study. Targeted Oncology. 20(1). 161–169.
3.
Kokubo, Masaki, Yukinori Matsuo, Masakazu Ogura, et al.. (2023). Major Cardiovascular Events after Chemoradiotherapy with or without Durvalumab in Patients with Stage III Non-Small Cell Lung Cancer: Supplementary Analysis. International Journal of Radiation Oncology*Biology*Physics. 117(2). e30–e31.
4.
Sakanaka, Katsuyuki, Hideaki Hirashima, Nobutaka Mukumoto, et al.. (2022). A case of a pregnant woman with locally advanced cervical esophageal cancer treated with definitive chemoradiotherapy. International Cancer Conference Journal. 11(4). 292–297.
5.
Matsuo, Yukinori, Takashi Shintani, Masakazu Ogura, et al.. (2022). Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer. Journal of Radiation Research. 64(1). 142–153.
6.
Shintani, Takashi, Yukinori Matsuo, Masakazu Ogura, et al.. (2021). Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab. Clinical Lung Cancer. 22(5). 401–410.
7.
Sakanaka, Katsuyuki, Kota Fujii, Hideaki Hirashima, et al.. (2021). Chemoradiotherapy for fistula-related perianal squamous cell carcinoma with Crohn’s disease. International Cancer Conference Journal. 10(4). 305–311.
8.
Sakanaka, Katsuyuki, Kota Fujii, & Takashi Mizowaki. (2020). Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report. BMC Cancer. 20(1). 21–21.
9.
Sakanaka, Katsuyuki, et al.. (2020). Radiation Dose-escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Oesophageal Squamous Cell Carcinoma: A Single-institution Phase I Study. Clinical Oncology. 33(3). 191–201.
10.
Sakanaka, Katsuyuki, et al.. (2020). Therapy-Related Acute Myeloid Leukemia 2 Months after Chemoradiotherapy for Esophageal Cancer: A Case Report. Case Reports in Oncology. 13(1). 299–303.
11.
Sakanaka, Katsuyuki, Kota Fujii, Shin’ichi Miyamoto, et al.. (2019). <p>Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma</p>. Cancer Management and Research. Volume 11. 3623–3630.
12.
Sakanaka, Katsuyuki, et al.. (2019). Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome. Journal of Radiation Research. 60(4). 517–526.
13.
Sakanaka, Katsuyuki, Kota Fujii, Satoshi Itasaka, et al.. (2018). Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma. Radiation Oncology. 13(1). 7–7.
14.
Doi, Toshifumi, Naoki Wakabayashi, N. Iwai, et al.. (2013). [Pancreatic pseudocyst with fistula to the common bile duct and the duodenum].. PubMed. 110(7). 1288–95.
15.
Minami, Masahito, Kota Fujii, Kojiro Mori, et al.. (2008). Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab. Journal of Medical Virology. 80(12). 2069–2078.
16.
Hamaguchi, Masahide, Takao Kojima, Yoshito Itoh, et al.. (2007). The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation. The American Journal of Gastroenterology. 102(12). 2708–2715.
17.
Hamaguchi, Masahide, Takao Kojima, Noriyuki Takeda, et al.. (2005). The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease. Annals of Internal Medicine. 143(10). 722–728.
18.
Isozaki, Hiroshi, Kota Fujii, Eiji Nomura, et al.. (1999). Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).. PubMed. 46(28). 2669–72.
19.
Fujita, Mayumi, Fukumi Furukawa, Kota Fujii, et al.. (1992). Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts. Archives of Dermatological Research. 284(3). 159–166.
20.
Morikawa, Shigehiro, Shinkichi Taniguchí, Kota Fujii, et al.. (1987). Preferential synthesis of diacyl and alkenylacyl ethanolamine and choline glycerophospholipids in rabbit platelet membranes.. Journal of Biological Chemistry. 262(3). 1213–1217.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Min‐Sun Kwak Breakdown of academic impact, for papers by Amitabh Suman Breakdown of academic impact, for papers by Amer Khiyami Breakdown of academic impact, for papers by Paolo De Paolis Breakdown of academic impact, for papers by Myung‐Whun Sung Breakdown of academic impact, for papers by Franco Sasso Breakdown of academic impact, for papers by Elsbeth Henderson Breakdown of academic impact, for papers by Enrico Mozzi Breakdown of academic impact, for papers by Rosa Lombardi Breakdown of academic impact, for papers by Paul C.L. Choi